Centre Paramédical Impulsion: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Centre Paramédical Impulsion
Largest movements
- Tangible fixed assets -€7,906
down €7,906 (-3.8%), from €207,357 to €199,451
of which Land and buildings: -€7,764
- Cash +€2,862
up €2,862 (+30.9%), from €9,260 to €12,122
mainly Depreciation (+€9,288) and Net result for the year (+€2,889)
- Debts after one year -€7,118
down €7,118 (-3.6%), from €197,526 to €190,408
- Profit (loss) carried forward +€2,889
up €2,889 (+91.6%), from €3,154 to €6,043
- Gross operating margin +€2,737
up €2,737 (+16.8%), from €16,249 to €18,986
- Depreciation +€1,192
up €1,192 (+14.7%), from €8,096 to €9,288
- Taxes +€853
up €853, from -€448 to €405
- Financial charges -€246
down €246 (-5.0%), from €4,892 to €4,646
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €218,078 | €213,885 | -€4,193 | -1.9% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €207,357 | €199,451 | -€7,906 | -3.8% |
| Tangible fixed assets | 22/27 | €207,357 | €199,451 | -€7,906 | -3.8% |
| Land and buildings | 22 | €201,896 | €194,132 | -€7,764 | -3.8% |
| Furniture and vehicles | 24 | €5,461 | €5,319 | -€142 | -2.6% |
| Current assets | 29/58 | €10,721 | €14,434 | +€3,713 | +34.6% |
| Amounts receivable within one year | 40/41 | €500 | €595 | +€95 | +18.9% |
| Other amounts receivable | 41 | €500 | €595 | +€95 | +18.9% |
| Cash at bank and in hand | 54/58 | €9,260 | €12,122 | +€2,862 | +30.9% |
| Deferred charges and accrued income | 490/1 | €961 | €1,718 | +€757 | +78.7% |
| Total equity and liabilities | 10/49 | €218,078 | €213,885 | -€4,193 | -1.9% |
| Equity | 10/15 | €13,154 | €16,043 | +€2,889 | +22.0% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €3,154 | €6,043 | +€2,889 | +91.6% |
| Amounts payable | 17/49 | €204,924 | €197,842 | -€7,082 | -3.5% |
| Amounts payable after more than one year | 17 | €197,526 | €190,408 | -€7,118 | -3.6% |
| Financial debts | 170/4 | €197,526 | €190,408 | -€7,118 | -3.6% |
| Amounts payable within one year | 42/48 | €6,898 | €7,118 | +€220 | +3.2% |
| Current portion of amounts payable after more than one year | 42 | €6,842 | €7,118 | +€276 | +4.0% |
| Trade debts | 44 | €56 | - | -€56 | |
| Suppliers | 440/4 | €56 | - | -€56 | |
| Accrued charges and deferred income | 492/3 | €501 | €317 | -€184 | -36.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,096 | €9,288 | +€1,192 | +14.7% |
| Other operating charges | 640/8 | €1,723 | €1,806 | +€83 | +4.8% |
| Gross operating margin | 9900 | €16,249 | €18,986 | +€2,737 | +16.8% |
| Operating profit (loss) | 9901 | €6,431 | €7,893 | +€1,462 | +22.7% |
| Financial income | 75/76B | - | €48 | +€48 | |
| Recurring financial income | 75 | - | €48 | +€48 | |
| Financial charges | 65/66B | €4,892 | €4,646 | -€246 | -5.0% |
| Recurring financial charges | 65 | €4,892 | €4,646 | -€246 | -5.0% |
| Profit (loss) for the period before taxes | 9903 | €1,539 | €3,295 | +€1,756 | +114% |
| Income taxes | 67/77 | -€448 | €405 | +€853 | |
| Profit (loss) for the period | 9904 | €1,987 | €2,889 | +€903 | +45.4% |
| Profit (loss) for the period to be appropriated | 9905 | €1,987 | €2,889 | +€903 | +45.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.